XML 21 R8.htm IDEA: XBRL DOCUMENT v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended 12 Months Ended
Jun. 30, 2019
Mar. 31, 2019
Jun. 30, 2018
Mar. 31, 2018
Jun. 30, 2019
Jun. 30, 2018
Dec. 31, 2018
Jun. 30, 2019
Dec. 31, 2018
Jun. 30, 2018
Operating activities:                    
Net income $ 68,960 $ 62,900 $ 80,362 $ 61,022 $ 131,860 $ 141,384        
Adjustments to reconcile net income to net cash provided by operating activities:                    
Depreciation and amortization         166,988 181,717        
Debt premium and discount amortization         948 (1,878)        
Deferred financing cost amortization         3,551 3,313        
Accretion of above- and below-market leases, net         (9,646) (14,822)        
Impairment of real estate assets 6,186   11,927   9,298 27,829        
Gain on sale of real estate assets         (20,645) (39,710)        
Equity based compensation, net         5,611 5,268        
Other         1,814 1,821        
Loss on extinguishment of debt, net         677 423        
Changes in operating assets and liabilities:                    
Receivables         (7,628) 8,697        
Deferred charges and prepaid expenses         (14,610) (15,054)        
Other assets         42 3,643        
Accounts payable, accrued expenses and other liabilities         (17,253) (22,278)        
Net cash provided by operating activities         251,007 280,353        
Investing activities:                    
Improvements to and investments in real estate assets         (169,529) (120,638)        
Acquisitions of real estate assets         (79,634) (7,453)        
Proceeds from sales of real estate assets         95,139 239,404        
Purchase of marketable securities         (24,202) (16,524)        
Proceeds from sale of marketable securities         38,942 13,197        
Net cash provided by (used in) investing activities         (139,284) 107,986        
Financing activities:                    
Repayment of secured debt obligations         0 (9,356)        
Repayment of borrowings under unsecured revolving credit facility         (337,000) (35,000)        
Proceeds from borrowings under unsecured revolving credit facility         176,000 35,000        
Proceeds from unsecured notes         399,216 0        
Repayment of borrowings under unsecured term loans         (200,000) (185,000)        
Deferred financing and debt extinguishment costs         (3,402) (440)        
Distributions to common stockholders         (167,772) (167,576)        
Repurchases of common shares         (14,563) (33,265)        
Repurchases of common shares in conjunction with equity award plans         (1,711) (1,855)        
Net cash used in financing activities         (149,232) (397,492)        
Net change in cash, cash equivalents and restricted cash         (37,509) (9,153)        
Cash, cash equivalents and restricted cash at beginning of period   50,765   110,777 50,765 110,777 $ 110,777      
Cash, cash equivalents and restricted cash at end of period 13,256   101,624   13,256 101,624 50,765      
Reconciliation to consolidated balance sheets:                    
Cash and cash equivalents 10,809   53,418   10,809 53,418 41,745      
Restricted cash               $ 2,447 $ 9,020 $ 48,206
Cash, cash equivalents and restricted cash at end of period 13,256 50,765 101,624 110,777 50,765 110,777 50,765 13,256 50,765 101,624
Supplemental disclosure of cash flow information:                    
Cash paid for interest, net of amount capitalized of $1,404 and $1,169         87,170          
Brixmor Operating Partnership LP                    
Operating activities:                    
Net income 68,960 62,900 80,362 61,022 131,860 141,384        
Adjustments to reconcile net income to net cash provided by operating activities:                    
Depreciation and amortization         166,988 181,717        
Debt premium and discount amortization         948 (1,878)        
Deferred financing cost amortization         3,551 3,313        
Accretion of above- and below-market leases, net         (9,646) (14,822)        
Impairment of real estate assets         9,298 27,829        
Gain on sale of real estate assets         (20,645) (39,710)        
Equity based compensation, net         5,611 5,268        
Other         1,814 1,821        
Loss on extinguishment of debt, net         677 423        
Changes in operating assets and liabilities:                    
Receivables         (7,628) 8,697        
Deferred charges and prepaid expenses         (14,610) (15,054)        
Other assets         42 3,643        
Accounts payable, accrued expenses and other liabilities         (17,253) (22,278)        
Net cash provided by operating activities         251,007 280,353        
Investing activities:                    
Improvements to and investments in real estate assets         (169,529) (120,638)        
Acquisitions of real estate assets         (79,634) (7,453)        
Proceeds from sales of real estate assets         95,139 239,404        
Purchase of marketable securities         (24,200) (16,524)        
Proceeds from sale of marketable securities         38,942 13,197        
Net cash provided by (used in) investing activities         (139,282) 107,986        
Financing activities:                    
Repayment of secured debt obligations         0 (9,356)        
Repayment of borrowings under unsecured revolving credit facility         (337,000) (35,000)        
Proceeds from borrowings under unsecured revolving credit facility         176,000 35,000        
Proceeds from unsecured notes         399,216 0        
Repayment of borrowings under unsecured term loans         (200,000) (185,000)        
Deferred financing and debt extinguishment costs         (3,402) (440)        
Partner distributions         (183,941) (202,694)        
Net cash used in financing activities         (149,127) (397,490)        
Net change in cash, cash equivalents and restricted cash         (37,402) (9,151)        
Cash, cash equivalents and restricted cash at beginning of period   50,639   110,747 50,639 110,747 110,747      
Cash, cash equivalents and restricted cash at end of period 13,237   101,596   13,237 101,596 50,639      
Reconciliation to consolidated balance sheets:                    
Cash and cash equivalents 10,790   53,390   10,790 53,390 41,619      
Restricted cash               2,447 9,020 48,206
Cash, cash equivalents and restricted cash at end of period $ 13,237 $ 50,639 $ 101,596 $ 110,747 $ 50,639 110,747 $ 50,639 $ 13,237 $ 50,639 $ 101,596
Supplemental disclosure of cash flow information:                    
Cash paid for interest, net of amount capitalized of $1,404 and $1,169           $ 109,453